4min chapter

Bloomberg Talks cover image

Novo Nordisk CEO Talks Weight Loss Drug Supply

Bloomberg Talks

CHAPTER

Exploring Long-Term Use and Administration Routes of Weight Loss Drugs

Exploring the debate around the continued use of weight loss drugs like GLP-1s, questioning if they are permanent solutions or if discontinuation is feasible post-achievement of weight loss goals. The chapter also touches on personalized medicine, varying patient needs, and the evolving landscape of medication administration from injectables to oral pills.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode